Dashboard
Manage Tickers

EXAS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

deal-dispatch-abbott-tpg-and-lonza-make-major-moves-mm-custard-and-new-fortress-energy-struggle
Deal Dispatch: Abbott, TPG And Lonza Make ...
11/21/2025 16:58:05

Abbott buys Exact Sciences for $21B; TPG invests $1B in Tata Consultancy; and New Fortress Energy is on bankruptcy watch.

wells-fargo-downgrades-exact-sciences-to-equal-weight-raises-price-target-to-105
Wells Fargo Downgrades Exact Sciences to E...
11/21/2025 15:30:07

Wells Fargo analyst Brandon Couillard downgrades Exact Sciences (NASDAQ:EXAS) from Overweight to Equal-Weight and raises the...

william-blair-downgrades-exact-sciences-to-market-perform
William Blair Downgrades Exact Sciences to...
11/21/2025 15:12:24

William Blair analyst Andrew Brackmann downgrades Exact Sciences (NASDAQ:EXAS) from Outperform to Market Perform.

guggenheim-downgrades-exact-sciences-to-neutral
Guggenheim Downgrades Exact Sciences to Ne...
11/21/2025 14:08:29

Guggenheim analyst Subbu Nambi downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Neutral.

barclays-downgrades-exact-sciences-to-equal-weight-raises-price-target-to-105
Barclays Downgrades Exact Sciences to Equa...
11/21/2025 13:39:14

Barclays analyst Luke Sergott downgrades Exact Sciences (NASDAQ:EXAS) from Overweight to Equal-Weight and raises the price t...

tech-stocks-fall-despite-nvidias-beat-walmart-jumps-6-whats-moving-markets-thursday
Tech Stocks Fall Despite Nvidia's Beat, Wa...
11/20/2025 17:43:19

Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lif...

nutex-health-posts-strong-q3-results-joins-pacs-group-walmart-cerence-and-other-big-stocks-moving-higher-on-thursday
Nutex Health Posts Strong Q3 Results, Join...
11/20/2025 16:36:00

abbotts-21-billion-exact-sciences-buyout-reshapes-cancer-diagnostics
Abbott's $21 Billion Exact Sciences Buyout...
11/20/2025 14:37:44

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highli...

Core News & Articles
CORRECTION: Exact Sciences Ticker Is 'EXAS'
11/20/2025 12:44:34

Core News & Articles
Abbott Signs Agreement To Acquire Exact Sc...
11/20/2025 12:31:56

Abbott (NYSE:ABT) and Exact Sciences (NASDAQ:EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences,...

exact-sciences-shares-resume-trade
Exact Sciences Shares Resume Trade
11/19/2025 18:48:29

Core News & Articles
UPDATE: 'Abbott Weighs Takeover of Cancer ...
11/19/2025 18:41:40

https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences

exact-sciences-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1395
Exact Sciences Shares Halted On Circuit Br...
11/19/2025 18:39:22

piper-sandler-maintains-overweight-on-exact-sciences-raises-price-target-to-80
Piper Sandler Maintains Overweight on Exac...
11/11/2025 17:01:37

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

exact-sciences-announces-expiration-hsr-waiting-period-for-license-to-freenomes-blood-based-colorectal-cancer-screening-tests-co-updates-fy25-adj-ebitda-guidance-to-reflect-initial-75m-cash-payment-sees-adj-ebitda-395m-405m
Exact Sciences Announces Expiration HSR Wa...
11/10/2025 12:10:06

exact-sciences-releases--validation-results-from-its-altus-study-showing-that-the-oncoguard-liver-blood-test-provides-superior-early-stage-and-overall-sensitivity-for-detecting-hepatocellular-carcinoma-compared-to-the-current-standard-of-care
Exact Sciences Releases Validation Result...
11/07/2025 13:06:30

Oncoguard® Liver blood test delivers seven times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus...

wells-fargo-maintains-overweight-on-exact-sciences-raises-price-target-to-85
Wells Fargo Maintains Overweight on Exact ...
11/05/2025 15:19:29

Wells Fargo analyst Brandon Couillard maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target f...

td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90
TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90
TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday
Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION